Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy

Por Kolluri, Krishna K., Laurent, Geoff J., Janes, Sam M.
Publicado em 2013

TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy

Por Yuan, ZhengQiang, Kolluri, Krishna K., Gowers, Kate H. C., Janes, Sam M.
Publicado no J Extracell Vesicles (2017)

Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy

Por Yuan, ZhengQiang, Kolluri, Krishna K., Sage, Elizabeth K., Gowers, Kate H.C., Janes, Sam M.
Publicado no Cytotherapy (2015)

Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy

Por Yuan, Zhengqiang, Lourenco, Sofia Da Silva, Sage, Elizabeth K., Kolluri, Krishna K., Lowdell, Mark W., Janes, Sam M.
Publicado no Cytotherapy (2016)

CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity

Por Vallath, Sabari, Sage, Elizabeth K., Kolluri, Krishna K., Lourenco, Sofia N., Teixeira, Vitor S., Chimalapati, Suneeta, George, P. Jeremy, Janes, Sam M., Giangreco, Adam
Publicado no Sci Rep (2016)

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma

Por Sage, Elizabeth K, Kolluri, Krishna K, McNulty, Katrina, Lourenco, Sofia Da Silva, Kalber, Tammy L, Ordidge, Katherine L, Davies, Derek, Gary Lee, Y C, Giangreco, Adam, Janes, Sam M
Publicado em 2014

LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development

Por Lu, Liwen, Teixeira, Vitor H, Yuan, ZhengQiang, Graham, Trevor A, Endesfelder, David, Kolluri, Krishna, Al-Juffali, Noura, Hamilton, Nicholas, Nicholson, Andrew G, Falzon, Mary, Kschischo, Maik, Swanton, Charles, Wright, Nicholas A, Carroll, Bernadette, Watt, Fiona M, George, Jeremy P, Jensen, Kim B, Giangreco, Adam, Janes, Sam M
Publicado em 2013